Holen Sie sich die Stockscreener-App
109.19
0.20%
0.22
Handel nachbörslich:
106.86
-2.33
-2.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$108.97
Offen:
$108.34
24-Stunden-Volumen:
12.85M
Relative Volume:
0.87
Marktkapitalisierung:
$191.01B
Einnahmen:
$170.78B
Nettoeinkommen (Verlust:
$14.28B
KGV:
15.67
EPS:
6.9687
Netto-Cashflow:
$22.28B
1W Leistung:
-1.91%
1M Leistung:
-6.99%
6M Leistung:
+10.49%
1J Leistung:
+61.76%
1-Tages-Spanne:
$107.48
$109.54
1-Wochen-Bereich:
$102.01
$111.60
52-Wochen-Spanne:
$55.51
$125.16
Citigroup Inc Stock (C) Company Profile
Firmenname
Citigroup Inc
Sektor
Branche
Telefon
(212) 559-1000
Adresse
388 GREENWICH STREET, NEW YORK, NY
Compare C vs JPM, BAC, HSBC, WFC, RY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
C
Citigroup Inc
|
109.19 | 190.62B | 170.78B | 14.28B | 22.28B | 6.9687 |
|
JPM
Jpmorgan Chase Co
|
287.52 | 778.71B | 279.84B | 56.78B | 100.87B | 20.01 |
|
BAC
Bank Of America Corp
|
48.52 | 348.50B | 195.40B | 30.63B | 43.43B | 3.8228 |
|
HSBC
Hsbc Holdings Plc Adr
|
85.97 | 294.26B | 134.96B | 21.97B | 105.99B | 5.9917 |
|
WFC
Wells Fargo Co
|
76.88 | 241.61B | 124.49B | 21.36B | -14.49B | 6.2615 |
|
RY
Royal Bank Of Canada
|
165.00 | 231.01B | 97.86B | 15.12B | 25.04B | 10.47 |
Citigroup Inc Stock (C) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-05-15 | Eingeleitet | TD Cowen | Hold |
| 2025-01-06 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-12-03 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-04-04 | Bestätigt | Evercore ISI | In-line |
| 2024-03-25 | Bestätigt | Wells Fargo | Overweight |
| 2024-03-14 | Hochstufung | Goldman | Neutral → Buy |
| 2024-02-14 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-01-30 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2024-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-01-09 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-08 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-03 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-18 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-09-07 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-18 | Hochstufung | Odeon | Hold → Buy |
| 2023-07-10 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-12-08 | Eingeleitet | Piper Sandler | Neutral |
| 2022-10-03 | Herabstufung | Goldman | Buy → Neutral |
| 2022-09-06 | Herabstufung | Odeon | Buy → Hold |
| 2022-05-27 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-03-07 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-03-03 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-12-15 | Hochstufung | Odeon | Hold → Buy |
| 2021-12-10 | Fortgesetzt | UBS | Neutral |
| 2021-12-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2021-06-16 | Bestätigt | Credit Suisse | Outperform |
| 2021-04-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2021-03-29 | Herabstufung | Edward Jones | Buy → Hold |
| 2021-01-21 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-06 | Eingeleitet | Daiwa Securities | Buy |
| 2021-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-11-19 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-15 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-08-18 | Herabstufung | Odeon | Hold → Sell |
| 2020-07-17 | Herabstufung | Odeon | Buy → Hold |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-07-07 | Hochstufung | Societe Generale | Hold → Buy |
| 2020-06-09 | Herabstufung | Standpoint Research | Buy → Hold |
| 2020-06-02 | Hochstufung | Odeon | Hold → Buy |
| 2020-05-18 | Hochstufung | Standpoint Research | Hold → Buy |
| 2020-04-20 | Hochstufung | Argus | Hold → Buy |
| 2020-04-14 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-04-01 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2020-02-03 | Herabstufung | Odeon | Buy → Hold |
| 2020-01-09 | Eingeleitet | DA Davidson | Buy |
| 2020-01-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-01-06 | Bestätigt | Goldman | Buy |
| 2019-07-26 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-05-30 | Hochstufung | Goldman | Neutral → Buy |
| 2019-02-22 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Citigroup Inc Aktie (C) Neueste Nachrichten
Citi's Sheets: May See Inflation Uptick in Coming Months - marketscreener.com
Citigroup (C) Issues First Digitally Native Structured Note via Euroclear - Insider Monkey
Citigroup (C) and Standard Chartered Evacuate Dubai Offices Amid Conflict - GuruFocus
Citi evacuates offices in the Middle East after Iran threatens to target banks - Business Insider
Pennon Group (LON:PNN) Given New GBX 636 Price Target at Citigroup - MarketBeat
Citigroup Forecasts Strong Price Appreciation for Centrica (LON:CNA) Stock - MarketBeat
Citigroup Lowers Price Target for Baxter International (BAX) Ami - GuruFocus
DXCM: Citigroup Raises Price Target, Maintains Buy Rating | DXCM Stock News - GuruFocus
ICLR: Citigroup Lowers Price Target Amid Neutral Rating | ICLR S - GuruFocus
Goldman, Citi Tell Staff to Exit Dubai Offices Amid Iran Threats - Bloomberg
iRhythm Holdings (IRTC) Sees Price Target Lowered by Citigroup | - GuruFocus
Citigroup Maintains Sell Rating on IART and Lowers Price Target - GuruFocus
Citigroup Raises Price Target for Pegasystems (PEGA) to $75 | PE - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Price Target Cut to $214.00 by Analysts at Citigroup - MarketBeat
Citigroup Lowers Integra LifeSciences (NASDAQ:IART) Price Target to $9.00 - MarketBeat
Citigroup Increases Johnson & Johnson (NYSE:JNJ) Price Target to $274.00 - MarketBeat
Citi adds consumer ABS to double-digit pipeline - GlobalCapital
Citigroup Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
DexCom (NASDAQ:DXCM) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat
BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at Citigroup - MarketBeat
Citigroup Issues Positive Forecast for Hewlett Packard Enterprise (NYSE:HPE) Stock Price - MarketBeat
Pegasystems (NASDAQ:PEGA) Price Target Raised to $75.00 at Citigroup - MarketBeat
Form 424B2 CITIGROUP INC - StreetInsider
Citigroup, Standard Chartered Evacuate Dubai Offices Amid Iran Threats - marketscreener.com
Citigroup Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price - MarketBeat
ISRG Upgraded to 'Buy' by Citigroup with Price Target Maintained at $590 | ISRG Stock News - GuruFocus
Citigroup : 2026 RBC Capital Markets Global Financial Institutions Conference Transcript - marketscreener.com
C's Turnaround Strengthens Growth Outlook: Should You Buy the Stock? - TradingView
Citi, StanChart evacuate Dubai offices, HSBC closes Qatar branches as fears grow - Reuters
Intuitive Surgical (NASDAQ:ISRG) Upgraded by Citigroup to "Buy" Rating - MarketBeat
Vestcor Inc Lowers Stock Holdings in Citigroup Inc. $C - MarketBeat
Franklin Resources Inc. Increases Citigroup Stake - National Today
PCJ Investment Counsel Ltd. Acquires Shares of 29,870 Citigroup Inc. $C - MarketBeat
Mackenzie Financial Corp Acquires 78,035 Shares of Citigroup Inc. $C - MarketBeat
Franklin Resources Inc. Has $3.34 Billion Stock Position in Citigroup Inc. $C - MarketBeat
Citigroup Adjusts Price Target on DexCom to $84 From $77, Maintains Buy Rating - marketscreener.com
Forvia slips despite support from Citigroup - marketscreener.com
Citigroup Adjusts Price Target on Boston Scientific to $94 From $102, Maintains Buy Rating - marketscreener.com
Citi's Isobel Nordstrom guides Asian banks through change - Asian Banking & Finance
Will Morgan Stanley's Strategic Collaborations Drive Long-Term Growth? (Revised) - TradingView
Did Citi’s New Debt Issuance And Digital Note Launch Just Shift Citigroup's (C) Investment Narrative? - Yahoo Finance Singapore
Citi Lifts Global AI Capex/ Revenue Forecasts for 2026-30 - AASTOCKS.com
Rapid AI Adoption Lifts Citigroup Capex and Revenue Forecasts - East & Partners
Citigroup’s First Digital Note Tests DLT Promise Against Undervalued Shares - simplywall.st
Citi Stock Rebounds As CEO Jane Fraser Paints A Bullish Picture - Investor's Business Daily
How Citigroup Plans to Achieve 5-6% Y/Y NII Growth in 2026? - The Globe and Mail
Citigroup (C) Stock Climbs on Positive ROTCE and Investment Banking Outlook - GuruFocus
Citigroup Maintains Buy Rating on SEI, Lowers Price Target to $6 - GuruFocus
Citi expects mid-teens growth in Q1 investment banking fees, shares up (C:NYSE) - Seeking Alpha
Citigroup forecasts sustained growth in its investment banking and markets businesses - marketscreener.com
OII: Citigroup Raises Price Target for Oceaneering International to $35 | OII Stock News - GuruFocus
Finanzdaten der Citigroup Inc-Aktie (C)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):